The purpose of this article is to share an educational tool that is relevant for use with individuals with diabetes. The Diabetes Risk/Improvement Scale readily conveys to the patient in simple terms the risks that are involved if proper lifestyle controls are not in place. Diabetes educators will find this tool useful for assessment of patients as well as meaningful to patients in preventing complications of diabetes mellitus.
Get full access to this article
View all access options for this article.
References
1.
Living With Diabetes: Interactive Diabetes Management Tool [computer program]. Version 2.0. Brentford, UK: GlaxoSmithKline; January 2004.
2.
Diabetes PHD risk assessment toolhttp://www.diabetes.org/diabetesphd/default.jsp. Accessed February 6, 2007.
3.
Seventh Report of the Joint National Commission on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute Web site. http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm. Accessed January 29, 2007.
4.
United Kingdom Prospective Diabetes Study Group.Intensive blood-glucose control with sulfonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet.1998;352:837-853.
5.
Diabetes Control and Complications Trial Research Group.The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med.1993;14:977-986.
6.
Factsheet No 23: smoking and diabetes. Action on Smoking and Health Web site. http://www.ash.org.uk/html/factsheets/html/fact23.html. Accessed January 29, 2007.
7.
DiabetesPrevention Program Research Group. The diabetes prevention program. Diabetes Care. 2002;25:2165-2171.
8.
De Block C, Leeuw I, VanGaal L. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care. 2005;28:1649-1655.
9.
Position statement: standards for outcomes measurement of diabetes self-management education. Diabetes Educ.2003;29:804, 808-810, 813-816.
10.
Pyorala K., Pedersen TR, Kjekshus J., Faergeman O., Olsson AG, Thorgeirsson G.Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20:614-620.
11.
National Guideline Clearinghouse.Seventh report of the Joint National Committee on Prevention, Evaluation, and Treatment of High Blood Pressure. http://www.guideline.gov . Accessed October 30, 2006.
